As of December 31, 2023, the balance due from four customers accounted for approximately 30%, 35%, 0%, and 19% of the Company’s total accounts receivable, respectively.
Anbio Biotechnology Debt Obligations
No debt relationships on recordNo publicly disclosed debt instruments or credit facilities found for Anbio Biotechnology.
Anbio Biotechnology Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Anbio Biotechnology.
Anbio Biotechnology Ownership
Holder
Name
Confidence
Evidence
NNNN-OWNER-GEODE-CAPITAL-MANAGEMENT-LLC
GEODE CAPITAL MANAGEMENT, LLC
90%
13F overlay lists GEODE CAPITAL MANAGEMENT, LLC as top holder; 8 tracked holders.
Anbio Biotechnology Extended Supply Chain Network
No secondary connectionsNo correlated companies found through shared supply chain relationships.